Fig. 3
The Kaplan–Meier curve analysis of OS (a), DFS (b), LRFS (c) and DMFS (d) for pCR LARC patients who did not receive ACT, who received 1–4 cycles of ACT and who received 5 or more cycles of ACT.
Fig. 3 | British Journal of Cancer
The Kaplan–Meier curve analysis of OS (a), DFS (b), LRFS (c) and DMFS (d) for pCR LARC patients who did not receive ACT, who received 1–4 cycles of ACT and who received 5 or more cycles of ACT.
